Source: Annual Congress 2005 - Paediatric asthma drug therapy
Disease area: Airway diseases, Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. M. Micic-Stanojevic, S. V. Smiljanic, Z. M. Zivkovic, S. D. Radic (Belgrade, Serbia And Montenegro). Efficacy of fluticasone propionate in infants younger than two years with asthma. Eur Respir J 2005; 26: Suppl. 49, 1048

Member's Comments

No comment yet.

Related content which might interest you: Ciclesonide and fluticasone propionate show comparable efficacy in children and adolescents with asthma Source: Eur Respir J 2004; 24: Suppl. 48, 346s Year: 2004 Efficiency of fluticasone propinate with salmeterol in asthmatic children during 1 years Source: Annual Congress 2009 - Drug treatment of childhood asthma: the controversies and the issues Year: 2009 Safety profile of ciclesonide as compared with fluticasone propionate in the treatment of children and adolescents with asthma Source: Eur Respir J 2004; 24: Suppl. 48, 346s Year: 2004 Salmeterol and fluticasone in pre-school children with newly-diagnosed asthma Source: Eur Respir J 2007; 30: Suppl. 51, 458s Year: 2007 Efficacy of fluticasone propionate on lung function and symptoms in wheezy infants Source: Eur Respir J 2004; 24: Suppl. 48, 464s Year: 2004 Montelukast compared with fluticasone proprionate in children with persistent asthma Source: ISSN=ISSN 1810-6838, ISBN=, page=267 Year: 2006 Efficacy and safety of ciclesonide compared with fluticasone propionate or budesonide in adolescent patients with persistent asthma Source: Eur Respir J 2007; 30: Suppl. 51, 458s Year: 2007 Growth in asthmatic children treated with fluticasone propionate Source: Eur Respir J 2002; 20: Suppl. 38, 218s Year: 2002 Effect of fluticasone and montelukast in school children with asthma Source: Eur Respir J 2007; 30: Suppl. 51, 459s Year: 2007 Efficacy of salmeterol/fluticasone propionate MDI versus higher dose fluticasone propionate in adolescent and adult asthmatics uncontrolled on fluticasone propionate alone Source: Eur Respir J 2003; 22: Suppl. 45, 438s Year: 2003 Low dose inhaled fluticasone propionate compared with montelukast in children 6-12 years old Source: Eur Respir J 2003; 22: Suppl. 45, 535s Year: 2003 Effect of inhaled corticosteroid fluticasone propionate on linear growth in preschool children with asthma Source: Annual Congress 2007 - Anti-inflammatory therapy for childhood asthma Year: 2007 Safety of Inhaled fluticasone propionate in children 2-4 years old Source: Eur Respir J 2003; 22: Suppl. 45, 133s Year: 2003 Is low dose inhaled fluticasone propionate safe in young children with asthma? Source: Annual Congress 2008 - Preschool wheezing: advances in diagnosis, phenotyping and therapy Year: 2008 Treatment effectiveness and exacerbations during one year with seretide compared to fluticasone propionate and salmeterol in mild-to-moderate asthma Source: Eur Respir J 2001; 18: Suppl. 33, 176s Year: 2001 Efficacy of high-dose inhaled fluticasone propionate in Indian patients having moderate asthma Source: Eur Respir J 2002; 20: Suppl. 38, 305s Year: 2002 The effects of fluticasone propionate in asthmatic patients Source: Eur Respir J 2004; 24: Suppl. 48, 125s Year: 2004 Fluticasone and montelukast in school children with asthma Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of pulmonary diseases II Year: 2008 Survival in COPD patients after regular use of fluticasone propionate and salmeterol Source: Eur Respir J 2003; 21: 559-560 Year: 2003 Efficacy and safety of ciclesonide compared with fluticasone propionate in patients with moderate to severe asthma Source: Eur Respir J 2006; 28: Suppl. 50, 206s Year: 2006